Cerity Partners LLC Exact Sciences Corp Transaction History

Cerity Partners LLC

  • $44.7 Billion
  • Q3 2024

A detailed history of Cerity Partners LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Cerity Partners LLC holds 16,329 shares of EXAS stock, worth $1.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,329
Previous 5,557 193.85%
Holding current value
$1.01 Million
Previous $234,000 374.79%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$42.43 - $70.83 $457,055 - $762,980
10,772 Added 193.85%
16,329 $1.11 Million
Q2 2024

Aug 13, 2024
SELL
$41.33 - $74.26 $86,793 - $155,946
-2,100 Reduced 27.43%
5,557 $234,000
Q1 2024

May 14, 2024
BUY
$56.27 - $73.77 $136,454 - $178,892
2,425 Added 46.35%
7,657 $528,000
Q4 2023

Jan 26, 2024
BUY
$59.06 - $75.72 $309,001 - $396,167
5,232 New
5,232 $387,000
Q2 2023

Aug 14, 2023
BUY
$62.68 - $95.05 $15,795 - $23,952
252 Added 3.08%
8,439 $792,000
Q1 2023

May 11, 2023
BUY
$47.19 - $70.77 $102,591 - $153,853
2,174 Added 36.15%
8,187 $555,000
Q4 2022

Feb 15, 2023
BUY
$30.35 - $53.15 $182,494 - $319,590
6,013 New
6,013 $297,000
Q2 2022

Aug 10, 2022
SELL
$35.61 - $76.23 $184,780 - $395,557
-5,189 Closed
0 $0
Q1 2022

Apr 25, 2022
SELL
$57.56 - $82.54 $45,299 - $64,958
-787 Reduced 13.17%
5,189 $362,000
Q4 2021

Feb 14, 2022
BUY
$72.5 - $100.68 $57,420 - $79,738
792 Added 15.28%
5,976 $463,000
Q3 2021

Oct 25, 2021
SELL
$90.24 - $124.05 $26,801 - $36,842
-297 Reduced 5.42%
5,184 $495,000
Q2 2021

Aug 11, 2021
BUY
$93.66 - $139.27 $21,260 - $31,614
227 Added 4.32%
5,481 $681,000
Q1 2021

Aug 11, 2021
BUY
$116.57 - $155.01 $349,710 - $465,030
3,000 Added 133.1%
5,254 $692,000
Q1 2021

May 12, 2021
SELL
$116.57 - $155.01 $85,678 - $113,932
-735 Reduced 24.59%
2,254 $297,000
Q4 2020

Feb 11, 2021
BUY
$99.61 - $142.12 $73,213 - $104,458
735 Added 32.61%
2,989 $396,000
Q3 2020

Nov 12, 2020
BUY
$72.92 - $102.01 $164,361 - $229,930
2,254 New
2,254 $230,000
Q1 2020

May 14, 2020
SELL
$37.9 - $104.44 $81,977 - $225,903
-2,163 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$77.66 - $99.74 $167,978 - $215,737
2,163 New
2,163 $200,000
Q3 2019

Oct 30, 2019
SELL
$90.37 - $122.49 $225,202 - $305,245
-2,492 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$89.51 - $118.04 $100,967 - $133,149
-1,128 Reduced 31.16%
2,492 $294,000
Q1 2019

May 14, 2019
SELL
$61.98 - $96.5 $31,175 - $48,539
-503 Reduced 12.2%
3,620 $314,000
Q4 2018

Feb 06, 2019
BUY
$56.04 - $82.66 $231,052 - $340,807
4,123 New
4,123 $260,000

Others Institutions Holding EXAS

# of Institutions
672
Shares Held
163M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email